Neogen Corporation (NEOG)Healthcare | Medical Devices | Lansing, United States | NasdaqGS
11.73 USD
-0.27
(-2.250%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 11.73 |
Hot Take ↕ | Oct. 10, 2026, 1:38 a.m. EDT
The long-term investment case is severely compromised by a catastrophic multi-year decline. Over the last nine years, the stock has lost over 71% of its value, driven by a brutal collapse in 2022 followed by continued weakness. The most recent annual performance shows another significant drop, confirming a structural deterioration in market valuation. Fundamentally, the company is currently unprofitable with negative operating margins and a forward P/E that implies a turnaround is priced in but not yet realized. There is no dividend to provide income, and the balance sheet carries meaningful debt against a small market cap. While the recent price action shows some stabilization, the underlying business metrics—negative returns on equity and assets—suggest the market is correctly pricing in significant operational challenges. The short-term outlook remains murky; while the statistical forecast model hints at a slight upward lean, its low reliability and the overwhelming bearish positioning in the options market suggest that any near-term bounce is likely a relief rally rather than a trend reversal. Investors should view this as a speculative turnaround play with high risk, rather than a core holding. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.208311 |
| AutoETS | 0.244949 |
| AutoARIMA | 0.246545 |
| MSTL | 0.254983 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 2.13 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 3.55 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 37.112 |
| Revenue per Share | 4.06 |
| Market Cap | 2,560,729,600 |
| Forward P/E | 29.08 |
| Beta | 1.79 |
| Profit Margins | -6.35% |
| Website | https://www.neogen.com |
As of Oct. 10, 2026, 1:38 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Put volume and open interest significantly exceed call volume across nearly all expirations, with deep out-of-the-money puts holding substantial open interest relative to calls. This indicates a strong hedging bias or bearish sentiment, despite the stock trading near its 52-week highs relative to the recent crash.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.0304568 |
| Address1 | 620 Lesher Place |
| All Time High | 48.85 |
| All Time Low | 0.122253 |
| Ask | 15.1 |
| Ask Size | 2 |
| Audit Risk | 9 |
| Average Analyst Rating | 2.0 - Buy |
| Average Daily Volume10 Day | 6,651,730 |
| Average Daily Volume3 Month | 3,185,931 |
| Average Volume | 3,185,931 |
| Average Volume10Days | 6,651,730 |
| Beta | 1.793 |
| Bid | 8.64 |
| Bid Size | 2 |
| Board Risk | 2 |
| Book Value | 9.557 |
| City | Lansing |
| Compensation As Of Epoch Date | 1,798,675,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.73 |
| Current Ratio | 3.896 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 12.045 |
| Day Low | 11.71 |
| Debt To Equity | 37.112 |
| Display Name | Neogen |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,791,318,600 |
| Earnings Call Timestamp Start | 1,791,318,600 |
| Earnings Timestamp | 1,791,316,800 |
| Earnings Timestamp End | 1,791,316,800 |
| Earnings Timestamp Start | 1,791,316,800 |
| Ebitda | 109,000,000 |
| Ebitda Margins | 0.1233 |
| Enterprise To Ebitda | 29.019 |
| Enterprise To Revenue | 3.578 |
| Enterprise Value | 3,163,029,760 |
| Eps Current Year | 0.32333 |
| Eps Forward | 0.40333 |
| Eps Trailing Twelve Months | -0.26 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 12.1266 |
| Fifty Day Average Change | -0.39660072 |
| Fifty Day Average Change Percent | -0.03270502 |
| Fifty Two Week Change Percent | 103.04568 |
| Fifty Two Week High | 14.26 |
| Fifty Two Week High Change | -2.5300007 |
| Fifty Two Week High Change Percent | -0.1774194 |
| Fifty Two Week Low | 5.37 |
| Fifty Two Week Low Change | 6.3599997 |
| Fifty Two Week Low Change Percent | 1.1843575 |
| Fifty Two Week Range | 5.37 - 14.26 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 619,882,200,000 |
| Float Shares | 217,328,023 |
| Forward Eps | 0.40333 |
| Forward P E | 29.082884 |
| Free Cashflow | 38,936,000 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 2,636 |
| Fullday Change | -0.27000046 |
| Fullday Change Percent | -2.2500038 |
| Fullday Price | 11.73 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.47397998 |
| Gross Profits | 419,000,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00749 |
| Held Percent Institutions | 1.1089801 |
| Implied Shares Outstanding | 218,306,034 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://www.neogen.com/Corporate/invest.html |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,780,185,600 |
| Last Split Date | 1,623,024,000 |
| Last Split Factor | 2:1 |
| Long Business Summary | Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. |
| Long Name | Neogen Corporation |
| Market | us_market |
| Market Cap | 2,560,729,600 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_339683 |
| Most Recent Quarter | 1,788,134,400 |
| Net Income To Common | -56,100,000 |
| Next Fiscal Year End | 1,811,721,600 |
| Non Diluted Market Cap | 2,958,607,957 |
| Number Of Analyst Opinions | 3 |
| Open | 11.99 |
| Operating Cashflow | 85,300,000 |
| Operating Margins | -0.00808 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.66 |
| Phone | 517 372 9200 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 11.73 |
| Post Market Time | 1,791,921,661 |
| Previous Close | 12.0 |
| Price Eps Current Year | 36.278725 |
| Price Hint | 2 |
| Price To Book | 1.2273725 |
| Price To Sales Trailing12 Months | 2.8967528 |
| Profit Margins | -0.06346 |
| Quick Ratio | 2.062 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.0 |
| Region | US |
| Regular Market Change | -0.27000046 |
| Regular Market Change Percent | -2.2500038 |
| Regular Market Day High | 12.045 |
| Regular Market Day Low | 11.71 |
| Regular Market Day Range | 11.71 - 12.045 |
| Regular Market Open | 11.99 |
| Regular Market Previous Close | 12.0 |
| Regular Market Price | 11.73 |
| Regular Market Time | 1,791,921,600 |
| Regular Market Volume | 2,338,490 |
| Return On Assets | -0.00137 |
| Return On Equity | -0.02668 |
| Revenue Growth | 0.065 |
| Revenue Per Share | 4.06 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 218,306,034 |
| Shares Percent Shares Out | 0.0543 |
| Shares Short | 11,846,307 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 10,582,185 |
| Short Name | Neogen Corporation |
| Short Percent Of Float | 0.0725 |
| Short Ratio | 2.85 |
| Source Interval | 15 |
| State | MI |
| Symbol | NEOG |
| Target High Price | 14.0 |
| Target Low Price | 14.0 |
| Target Mean Price | 14.0 |
| Target Median Price | 14.0 |
| Total Cash | 172,000,000 |
| Total Cash Per Share | 0.788 |
| Total Debt | 774,300,032 |
| Total Revenue | 884,000,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.26 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.1379 |
| Two Hundred Day Average Change | 1.5920992 |
| Two Hundred Day Average Change Percent | 0.15704428 |
| Type Disp | Equity |
| Volume | 2,338,490 |
| Website | https://www.neogen.com |
| Zip | 48,912-1595 |